PRT-811
Prelude Therapeutics
['melsm', 'melanoma']
prt811 elicits responses and shows safety in advanced glioma and uveal melanoma #asco23 #asco2023 #btsm #melsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.